| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |